ENRIQUE
CASADO SAENZ
PROFESOR DOCTOR
![Foto de Cristóbal](/img/nophoto.png)
Cristóbal
Belda Iniesta
Publications dans lesquelles il/elle collabore avec Cristóbal Belda Iniesta (32)
2012
-
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer
Journal of Gastrointestinal Cancer, Vol. 43, Núm. 2, pp. 181-189
-
Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target
International Journal of Radiation Oncology Biology Physics, Vol. 84, Núm. 5, pp. 1151-1158
2011
-
A combined strategy of SAGE and quantitative PCR provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer
Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4145-4154
-
Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy
Colorectal Disease, Vol. 13, Núm. 9, pp. 989-998
2009
-
Chemotherapy for colorectal cancer in the elderly: Whom to treat and what to use
Cancer Treatment Reviews, Vol. 35, Núm. 3, pp. 246-254
-
Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: Multicenter phase II study
Cancer Chemotherapy and Pharmacology, Vol. 63, Núm. 3, pp. 403-409
-
EPO-R expression patterns in resected gastric adenocarcinoma followed by adjuvant chemoradiation treatment
Pathology and Oncology Research, Vol. 15, Núm. 1, pp. 1-10
-
KRAS mutations in primary colorectal cancer tumors and related metastases: A potential role in prediction of lung metastasis
PLoS ONE, Vol. 4, Núm. 12
-
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy
International Journal of Colorectal Disease, Vol. 24, Núm. 7, pp. 741-748
-
The combination of FOLFOX4 and bevacizumab may enable salvage surgery of unresectable liver metastases in colon cancer
Anti-Cancer Drugs, Vol. 20, Núm. SPEC. ISS. 1
2008
-
Cardiac toxicity: Old and new issues in anti-cancer drugs
Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 35-46
-
EGFR and colon cancer: A clinical view
Clinical and Translational Oncology, Vol. 10, Núm. 1, pp. 6-13
-
Retroperitoneal Castleman's disease with colon cancer. A rare association
Clinical and Translational Oncology, Vol. 10, Núm. 4, pp. 238-240
2007
-
Carcinoma de pulmón
Tratado de medicina paliativa y tratamiento de soporte del paciente con cáncer (Editorial Médica Panamericana), pp. 111-128
-
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study
Lancet Oncology, Vol. 8, Núm. 10, pp. 889-897
-
Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cells
Cancer Biology and Therapy, Vol. 6, Núm. 10, pp. 1600-1605
-
Molecular markers in colorectal cancer: Genetic bases for a customised treatment
Clinical and Translational Oncology, Vol. 9, Núm. 9, pp. 549-554
-
New screening method for lung cancer by detecting volatile organic compounds in breath
Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 364-368
-
Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma
Free Radical Research, Vol. 41, Núm. 6, pp. 681-687
-
Síndrome de anorexia-caquexia: aspectos generales y fisiopatología
Tratado de medicina paliativa y tratamiento de soporte del paciente con cáncer (Editorial Médica Panamericana), pp. 405-409